Sign in

DIAMOND Research Programme

@diamond-derx.bsky.social
81 followers 188 following 73 posts

Innovating Methods | Advancing Deprescribing Based at RCSI (bsky.app/profile/rcsi.bsky.social), led by Prof Frank Moriarty (@frankmoriarty.bsky.social) and funded by Wellcome. Find out more about our work here: diamond-deprescribing.eu

PostsRepliesMedia
DIAMOND Research Programme @diamond-derx.bsky.social · 02/09/2026
​DIAMOND's @jessicagoml.bsky.social presents her work on how gap choice affects estimates of benzodiazepine and Z‑drug discontinuation in dispensing data. #ISPEAnnual2026 #DIAMOND #deprescribing #DePhaRM​ ​
000
DIAMOND Research Programme @diamond-derx.bsky.social · 02/09/2026
The final day of #ISPEAnnual2026 shows no signs of losing momentum — a diverse programme packed with sessions on treatment‑effect heterogeneity, drug utilisation, neuropsychiatric safety, modern disease‑course epidemiology, real‑world economics, and more. #DIAMOND #deprescribing​ ​
000
DIAMOND Research Programme @diamond-derx.bsky.social · 01/09/2026
​Our #DePhaRM colleague Dr Zakir Khan shared a stratified disproportionality analysis on signals for adverse drug withdrawal events across US and EU pharmacovigilance databases. #ISPEAnnual2026 #DIAMOND #deprescribing #DePhaRM​
000
DIAMOND Research Programme @diamond-derx.bsky.social · 01/09/2026
Our #DePhaRM colleague Alex McKibben shared a comparative analysis of medication counting approaches in national dispensing data — a cohort study with important implications for exposure measurement. #ISPEAnnual2026 #DIAMOND #deprescribing​
000
DIAMOND Research Programme @diamond-derx.bsky.social · 01/09/2026
DIAMOND's Dr Anais Essilini presents her work validating new approaches to identify serotonin syndrome in pharmacovigilance data. #ISPEAnnual2026 #DIAMOND #deprescribing #DePhaRM​​
000
DIAMOND Research Programme @diamond-derx.bsky.social · 01/09/2026
​ Day 2 of #ISPEAnnual2026 continues with a jam-packed programme for the day ahead including oral and poster presentations, symposia and workshops, panels and a hot topics session. ​#DIAMOND #deprescribing #DePhaRM ​
000
DIAMOND Research Programme @diamond-derx.bsky.social · 31/08/2026
DIAMOND's Dr Ryan Muddiman delivering an oral presentation on analysing prescription intervals in primary care to inform drug‑specific exposure time. #ISPEAnnual2026 #DIAMOND #deprescribing #DePhaRM​
000
DIAMOND Research Programme @diamond-derx.bsky.social · 31/08/2026
Our #DePhaRM colleague Dr Constanza Saka showcases a systematic review on the accuracy of diagnostic codes and algorithms for identifying systemic lupus erythematosus in EHRs. Poster on display at Exhibit Hall, A‑290. #ISPEAnnual2026 #DIAMOND #deprescribing​
030
DIAMOND Research Programme @diamond-derx.bsky.social · 31/08/2026
Also presenting a poster at #ISPEAnnual2026 is #DIAMOND's Dr Ryan Muddiman, who shares findings from a simulation study comparing methods to estimate deprescribing effectiveness from observational data. You can catch Ryan at A-242 in the Exhibit Hall. ​
000
DIAMOND Research Programme @diamond-derx.bsky.social · 31/08/2026
DIAMOND's Dr @annsinead.bsky.social presents her work on prescribing cascades in Dutch older adults using routine GP data. You can visit her poster in the Exhibit Hall, A‑183. #ISPEAnnual2026 #DIAMOND #deprescribing #DePhaRM​
000
DIAMOND Research Programme @diamond-derx.bsky.social · 31/08/2026
A thought-provoking start to Day 1 at #ISPEAnnual2026 with the keynote from Peter Arlett of the European Medicines Agency. Peter highlighted the context that influences the real world and thus real world data, with implications for future evidence generation #DIAMOND #deprescribing ​
100
DIAMOND Research Programme @diamond-derx.bsky.social · 31/08/2026
Gianluca Trifirò, Scientific Program Chair of #ISPEAnnual2026, outlining Italy's long standing history in pharmacoepidemiology #DIAMOND #deprescribing
000
DIAMOND Research Programme @diamond-derx.bsky.social · 31/08/2026
Day 1 of #ISPEAnnual2026 begins with an opening address from ISPE President Ursula Kirchmayer who welcomed attendees to Milan
000
DIAMOND Research Programme @diamond-derx.bsky.social · 29/04/2026
Posters, panels, poutine – that's a wrap for the DIAMOND, DePhaRM & RCSI contingent ! #ICOD2026 #DIAMOND #deprescribing
020
DIAMOND Research Programme @diamond-derx.bsky.social · 29/04/2026
A whirlwind few days at #ICOD2026 packed with diverse topics & engaging #deprescribing discussions. Plenty for the #DIAMOND team to reflect on as we return to Ireland. Thanks to @caden-recad.bsky.social , @deprescribeus.bsky.social & the #ICOD2026 planning committee for such an engaging event
030
DIAMOND Research Programme @diamond-derx.bsky.social · 29/04/2026
Clare Howard delivering the #ICOD2026 closing keynote "Research versus the real world: getting the balance right" by passionately outlining the great work done in England including data-driven insights & the polypharmacy action learning sets. An inspiring end to #ICOD2026 #DIAMOND #deprescribing
010
DIAMOND Research Programme @diamond-derx.bsky.social · 29/04/2026
#ICOD2026 continues with a breadth sessions to choose from including panels & workshops on sedative use, paediatric psychotropic polypharmacy, evidence-based & inclusive tools for deprescribing &implementation science approaches to stakeholder-informed interventions #DIAMOND #deprescribing
000
DIAMOND Research Programme @diamond-derx.bsky.social · 29/04/2026
#ICOD2026 continues with the concurrent sessions. DePhaRM colleague Zakir Khan delivering an oral presentation on his overview of reviews that examined adverse drug withdrawal reactions after medication discontinuation, part of the HEAD-P project. #DIAMOND #deprescribing
010
DIAMOND Research Programme @diamond-derx.bsky.social · 29/04/2026
#DIAMOND's Ryan Muddiman presenting again today with findings from a cohort study examining medication interval patterns amongst older adults in primary care #deprescribing #ICOD2026
021
DIAMOND Research Programme @diamond-derx.bsky.social · 29/04/2026
DePhaRM's Alex McKibben presents findings from her systematic review of international guidelines to identify patients for medication review in primary care. #ICOD2026 #DIAMOND #deprescribing
021
DIAMOND Research Programme @diamond-derx.bsky.social · 29/04/2026
DePhaRM's Zakir Khan presenting his work on adverse drug withdrawal events reported in US & EU pharmacovigilance databases #DIAMOND #deprescribing #ICOD2026
031
DIAMOND Research Programme @diamond-derx.bsky.social · 29/04/2026
#DIAMOND's Anais Essilini presenting findings from an overview of reviews on medications associated with serotonin syndrome. Her work underscores the challenges of evidence synthesis for rare serious adverse events where reports are dominated by case reports #ICOD2026 #DIAMOND #deprescribing
072
DIAMOND Research Programme @diamond-derx.bsky.social · 29/04/2026
The morning kicking off with a plenary talk from Muhammad Mamdani on Applied AI in healthcare and the implications for #deprescribing, with #DIAMOND PI @frankmoriarty.bsky.social delivering the speaker introduction
021
DIAMOND Research Programme @diamond-derx.bsky.social · 29/04/2026
Another busy day at #ICOD2026 for the #DIAMOND & DePhaRM teams with poster and oral presentations today. Be sure to check out the poster sessions to speak with Anais Essilini, Ryan Muddiman & Alex McKibben about their work. Later this morning Zakir Khan will deliver an oral presentation
000
DIAMOND Research Programme @diamond-derx.bsky.social · 28/04/2026
DIAMOND's @annsinead.bsky.social joins James Sheppard and John Tazare on a panel moderated by DIAMOND's @frankmoriarty.bsky.social to explore methodological challenges in studying deprescribing with real-world data. Lots of interest in this discussion. #ICOD2026 #DIAMOND #deprescribing
131
DIAMOND Research Programme @diamond-derx.bsky.social · 28/04/2026
RCSI colleague and member of @frankmoriarty.bsky.social's DePhaRM group, Zakir Khan joins Ariel Green, Shin Liau, and Orla Sheehan for a panel discussion, moderated by @reeve-research.bsky.social on understanding adverse drug withdrawal events in #deprescribing. #ICOD2026 #DIAMOND
011
DIAMOND Research Programme @diamond-derx.bsky.social · 28/04/2026
Another RCSI colleague, Caroline McCarthy, now moderating a Fireside Chat with Ross Upshur on "Becoming what you research" at #ICOD2026. #DIAMOND #deprescribing
021
DIAMOND Research Programme @diamond-derx.bsky.social · 28/04/2026
Also lovely to get a chance to catch up with other RCSI colleagues at #ICOD2026. A networking lunch on "Health literacy and deprescribing" today which is moderated by RCSI's Patrick Moynagh #DIAMOND #deprescribing
000
DIAMOND Research Programme @diamond-derx.bsky.social · 28/04/2026
#ICOD2026 continues with the scientific abstracts plenary. Diverse topics including #deprescribing prophylactic antibiotics for UTIs, comparing HCP application of STOPP/START, meds management in cognitively impaired older adults, antihypertensive deprescribing and strengthening pharmacovigilance
120
DIAMOND Research Programme @diamond-derx.bsky.social · 28/04/2026
Ryan Muddiman presenting a poster examining several estimation approaches in #deprescribing using simulation methods. He generated complex event history data resembling EHR data & measured performance when targeting specific estimands of stopping medication vs. continued use #ICOD2026
011
DIAMOND Research Programme @diamond-derx.bsky.social · 28/04/2026
Jessica Gómez Lemus presenting her #ICOD2026 poster, which examines how #deprescribing is defined, measured & validated in routine data. She found substantial variation across 102 studies; discontinuation mainly defined using gap-based approaches; and validation infrequently reported #DIAMOND
021
DIAMOND Research Programme @diamond-derx.bsky.social · 28/04/2026
An engaging panel at #ICOD2026 today featuring @reeve-research.bsky.social, @mikesteinman.bsky.social & Wade Thompson, moderated by @lisamccarthy.bsky.social focused on #deprescribing guidelines as a global strategy for medication optimisation #DIAMOND
020
DIAMOND Research Programme @diamond-derx.bsky.social · 28/04/2026
Today's #ICOD2026 opening keynote being delivered by Andre Picard- "When less is more: How to communicate the deprescribing message to the public" #DIAMOND#deprescribing
030
DIAMOND Research Programme @diamond-derx.bsky.social · 28/04/2026
A packed day 2 of #ICOD2026 for the DIAMOND & DePharRM teams, with poster and panel presentations lined up. Be sure to visit Jessica Gomez Lemus & Ryan Muddiman's posters on display today between 10:15 and 11:30am and again between 2:00 and 3:15pm. #DIAMOND #deprescribing
000
DIAMOND Research Programme @diamond-derx.bsky.social · 27/04/2026
#ICOD2026 opening keynote being delivered by Prof Cynthia Boyd, who shares reflections on pragmatic approaches to #deprescribing
010
DIAMOND Research Programme @diamond-derx.bsky.social · 27/04/2026
Elder Otsi’tsaken:ra (Charlie Patton), a respected Kanien’kehá:ka (Faithkeeper) from Kahnawà:ke, delivering the Ohén:ton Karihwatéhkwen (Thanksgiving Address), "The Words Before All Else", opening address at #ICOD2026 #DIAMOND #deprescribing
000
DIAMOND Research Programme @diamond-derx.bsky.social · 27/04/2026
@dremilymcd.bsky.social kicking off proceedings with the #ICOD2026 welcoming address. #ICOD2026 #DIAMOND #deprescribing
031
DIAMOND Research Programme @diamond-derx.bsky.social · 27/04/2026
Shout out to our RCSI colleague, Caroline McCarthy, who is taking part in a pre-conference panel on "How we prepare clinicians to deprescribe? An international perspective" #ICOD2026 #DIAMOND #deprescribing
011
DIAMOND Research Programme @diamond-derx.bsky.social · 27/04/2026
​DIAMOND collaborator Wade Thompson also on the #ICOD2026 program with a pre-conference workshop on "From preferences to practice: applying preference research to advance deprescribing" with Ariel Green & Aisling McEvoy. #ICOD2026 #DIAMOND #deprescribing
011
DIAMOND Research Programme @diamond-derx.bsky.social · 27/04/2026
The #ICOD2026 pre-conference networking continues with the @deprescribeus.bsky.social Early Career Investigator meeting. Lovely to see UCC's Kieran Dalton as a panelist on the moderated panel on navigating your early-career path. Also feat Michelle Keller, Jinjiao Wang, moderated by Amanda Mixon
121
DIAMOND Research Programme @diamond-derx.bsky.social · 27/04/2026
DIAMOND's @annsinead.bsky.social & @frankmoriarty.bsky.social kick off the morning by catching up with colleagues from @deprescribeus.bsky.social at the #ICOD2026 USDeN Junior Investigator breakfast. #DIAMOND #deprescribing
021
DIAMOND Research Programme @diamond-derx.bsky.social · 27/04/2026
Day 1 at #ICOD2026 – pre-conference events kicking things off and great deprescribing conversations already starting. #DIAMOND #deprescribing
000
DIAMOND Research Programme @diamond-derx.bsky.social · 06/03/2026
Making plans for next week? Why not add our Patient Safety Awareness Week webinar on Monday 9th March to your calendar? ​ 📌 “How can we harness existing data sources to maximise medication and patient safety?”​ ⏰ Monday 9th March 3pm GMT 💻 Register here: bit.ly/3Oa9haA%E2%8...
000
DIAMOND Research Programme @diamond-derx.bsky.social · 02/03/2026
⏰One week to go! Join us on Monday 9th March at 3pm (GMT) by registering at bit.ly/3Oa9haA for the webinar link.
000
DIAMOND Research Programme @diamond-derx.bsky.social · 23/02/2026
Only two weeks until our Patient Safety Awareness Week webinar on Monday 9th March at 3pm (GMT)! Be sure to register at bit.ly/3Oa9haA for the webinar link.
010
DIAMOND Research Programme @diamond-derx.bsky.social · 16/02/2026
📢️ Webinar Announcement 📢️​ We're marking Patient Safety Awareness Week 8-14th March 2026 with a special Teams webinar on Monday 9th March 2026 at 3pm: ​ “How can we harness existing data sources to maximise medication and patient safety?” 🗓️Register here: bit.ly/3Oa9haA
112
DIAMOND Research Programme @diamond-derx.bsky.social · 21/01/2026
We are pleased to share our latest publication in Pharmacoepidemiology and Drug Safety (PDS). 🔗https://doi.org/10.1002/pds.70329​ We reviewed statistical simulations published in PDS, the flagship #pharmacoepidemiology journal, between 2017 and 2024 and focused on implementation & reporting. 1/4
121
DIAMOND Research Programme @diamond-derx.bsky.social · 09/01/2026
Here at DIAMOND, we are settling into 2026-calendars are filling up and we continue making plans for the year ahead. For many, January is the time for resolutions-big or small, personal or professional. ⤵️
100
DIAMOND Research Programme @diamond-derx.bsky.social · 11/07/2025
It's World Benzodiazepine Awareness Day! 💊 ​ For the UN Decade of Healthy Ageing, the WHO’s new monitoring framework recognises safe medication use as a cornerstone of ageing well, including indicators for older persons: 🔹Prescribed benzodiazepines for >1 year ​ 🔹Taking 5+ medications daily 1/n
131
Reposted by DIAMOND Research Programme
Frank Moriarty @frankmoriarty.bsky.social · 27/06/2025
Just ten days left to apply for this Research Fellow position, focused on pharmacoepidemiology and deprescribing. More information about the DIAMOND programme available at: diamond-deprescribing.eu Full job description here (deadline July 7th): my.corehr.com/pls/rcsirecr...
diamond-deprescribing.eu
Home
DIAMOND is an ambitious Wellcome-funded programme of research that aims to develop and advance novel methods for researching deprescribing by harnessing big data.
112